TRIM59 and neoplasm: A previous study used Immunohistochemistry (IHC) to determine the expression of TRIM59 in 291 cases of 37 tumor types, and found that TRIM59 expression was upregulated in tumor samples, particularly in lung, breast, liver, skin, tongue and mouth (squamous cell cancer) and endometrial cancers [9].